amendment2022-03-18active
Arzneimittel-Richtlinie/Anlage XII: Dolutegravir (Neues Anwendungsgebiet: HIV-Infektion, Kinder ≥ 4 Wochen bis < 6 Jahre) - Änderung der Befristung der Geltungsdauer
Open official decision page ↗
G-BA source · retrieved 2026-08-05
Decision orientation
What the G-BA did
3 cited claims
Each claim links to the official G-BA page or an exact PDF page range.
Official metadata
- Decision date
- 2022-03-18
- Effective
- 18.03.2022
- Action type
- amendment
- Committee
- Arzneimittel
Case context
Listed normative targets
directiveArzneimittel-Richtlinie
A listed target is not treated as a new directive version unless an official version source exists.
Official document package